A Novel Flow Cytometry Array for High Throughput Detection of SARS-CoV-2 Antibodies
This novel, flexible multiplex bead-based assay utilizing a well-established platform provides a rapid and reproducible approach for detecting SARS-CoV-2-specific antibodies. Its high throughput capacity and low variability make it well suited for large-scale epidemiological, vaccine, and therapeutic studies. The platform's adaptability further supports application to other infectious diseases, offering an ideal tool for broad immunological surveillance.
Authors
- Brianne Petritis
- Kelly Whittaker
- Jianmin Fang (ORCID: https://orcid.org/0000-0002-4745-1146)
- Zhuo Zhang (ORCID: https://orcid.org/0000-0001-6496-8414)
- Rani Huang
- Benyue Zhang (ORCID: https://orcid.org/0000-0002-3610-3517)
- Jingqiao Lü (ORCID: https://orcid.org/0009-0009-8878-0235)
- Ruo‐Pan Huang (ORCID: https://orcid.org/0000-0002-5884-8026)
- Yichao Zhao (ORCID: https://orcid.org/0000-0002-1190-5396)
Institutions
- Biocure (United States) (US)
- RayBiotech (China) (CN)
Publication Details
- Journal
- Vaccines
- Published
- 2025-10-17
- DOI
- https://doi.org/10.3390/vaccines13101063
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00